Status:
UNKNOWN
Ahmed Glaucoma Valve Alone, With Amniotic Membrane or With Mitomycin C (MMC) for Treatment of Refractory Glaucoma
Lead Sponsor:
Shahid Beheshti University of Medical Sciences
Conditions:
Refractory Glaucoma
Eligibility:
All Genders
7-75 years
Phase:
PHASE1
Brief Summary
This randomized, controlled trial (RCT) compares the efficacy and safety of Ahmed Glaucoma Valve (AGV) implantation alone, with 3 minutes MMC application or with a single layer coverage of amniotic me...
Eligibility Criteria
Inclusion
- patients with refractory glaucoma
Exclusion
- children under 7 years old
- adults above 75 years old
- uncooperative patients
- patients underwent the operation for second time
- patients with major operation with AGV
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00893490
Last Update
May 6 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ophthalmic Research Center
Tehran, Tehran Province, Iran, 166666